Literature DB >> 2370019

Obscure anaemia and hepatic dysfunction in Castleman's disease.

T Featherstone1, A P Bayliss, S W Ewen, P W Brunt, A A Dawson.   

Abstract

A case is reported illustrating a rare and puzzling cause of long standing anaemia and abnormal liver function tests. The diagnosis of Castleman's disease came to light only after an adrenal mass was noted during ultrasound examination. Removal of the mass led to a rapid reversal of all the abnormalities.

Entities:  

Mesh：

Year:  1990        PMID： 2370019      PMCID： PMC1378547          DOI： 10.1136/gut.31.7.834

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  8 in total

1.  INTRATHORACIC LYMPHOID HAMARTOMA.

Authors:  E HIRST; H B WILLIAMS
Journal:  Thorax       Date:  1964-09       Impact factor: 9.139

2.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

3.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

4.  Lymphoid hamartoma.

Authors:  M R Abell
Journal:  Radiol Clin North Am       Date:  1968-04       Impact factor: 2.303

5.  A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients.

Authors:  G Frizzera; P M Banks; G Massarelli; J Rosai
Journal:  Am J Surg Pathol       Date:  1983-04       Impact factor: 6.394

6.  Castleman disease: unusual manifestations of an unusual disorder.

Authors:  G Olscamp; G Weisbrod; D Sanders; N Delarue; R Mustard
Journal:  Radiology       Date:  1980-04       Impact factor: 11.105

7.  Mesenteric Castleman tumor.

Authors:  E Iida; A Kohno; T Mikami; H Kumekawa; S Akimoto; K Hamano
Journal:  J Comput Assist Tomogr       Date:  1983-04       Impact factor: 1.826

8.  Multicentric giant lymph node hyperplasia.

Authors:  A R Gaba; R S Stein; D L Sweet; D Variakojis
Journal:  Am J Clin Pathol       Date:  1978-01       Impact factor: 2.493
  8 in total
  3 in total

Review 1.  Portal hypertension and refractory ascites associated with multicentric Castleman's disease.

Authors:  M Abarca; R J Andrade; A García-Arjona; J L Escolar; A Blanes; J M García-Hirschfeld; P González-Santos
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  Nodular regenerative hyperplasia of the liver and Castleman's disease: potential role of interleukin-6.

Authors:  Ayako Kiyuna; Takashi Sunagawa; Akira Hokama; Masato Touyama; Ryosaku Tomiyama; Hiroshi Sakugawa; Fukunori Kinjo; Atsushi Saito
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

3.  Obscure anaemia and hepatic dysfunction in Castleman's disease.

Authors:  I A Finnie; I T Gilmore
Journal:  Gut       Date:  1991-01       Impact factor: 23.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.